Resources by service
Almac’s enhanced RNA-Seq reporting solution claraT – Simplifying complex biologies within the Hallmarks of Cancer
RNA Sequencing (RNA-seq) is an increasingly popular technology for biomarker discovery in cancer research. High-throughput RNA-seq produces large quantities of complex data that require computational bioinformatics
pipelines to enable interpretation.
Almac Diagnostic Services has developed claraT – A unique software-driven solution, classifying biologically relevant gene expression signatures into a comprehensive, easy-to-interpret report.
The claraT report outputs include the entire study cohort and individual sample reports from Almac internally developed bioinformatics pipelines. claraT reports on relevant public and proprietary gene expression signatures as well as single gene targets within the Hallmarks of Cancer using Almac’s optimised RNA exome panel.
What you will learn:
- The structure and layout of the claraT report
- A detailed walk through of both the cohort and sample summaries
- How the claraT report can support biomarker discovery
- Future plans for developing the claraT report
*By submitting your information you acknowledge that you have read the privacy statement and you consent to our processing the data in accordance with that privacy statement. We may, from time to time, send you material relevant to your interests. If you change your mind at any time about wishing to receive material from us, you can send an email to firstname.lastname@example.org. Every email we send you will also include an unsubscribe link so you can unsubscribe from our marketing list.